Biotronik Rolls Out Biomonitor III Injectable Cardiac Monitor
Executive Summary
The company says Biomonitor III documents suspected arrhythmias or unexplained syncope in patients who have experienced cardiac arrhythmias or who are at risk for cardiac arrhythmias.
You may also be interested in...
Minute Insight: Biotronik Launches Remote Monitor That Can Prevent Heart Failure Hospitalizations
The HeartInsight algorithm combines heart failure parameters into a predictive score and alerts physicians if a patient with an implanted ICD or CRT-D is at higher risk of hospitalization. Biotronik will roll out HeartInsight in Europe in April.
Biotronik Adds Temperature Sensing To Biomonitor IIIm Injectable Cardiac Monitor
The US FDA cleared the Vital Data Sensor, which identifies body temperature increases that can indicate a fever caused by an infection.
Interview: New Biotronik CMO David Hayes Builds Physician Education, Clinical Trial Relationships
In an interview with Medtech Insight, Biotronik president Ryan Walters explained why the former Mayo Clinic cardiologist was the right choice to be the first CMO in the company's history and David Hayes discussed his reasons for taking the job.